RHUMBLINE ADVISERS

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1115418 BOSTON, MA

Position in TSHA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,042,829

+$887,200 QoQ

Shares Held

299,975

+16.0% QoQ

Ownership

0.092%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#71

of 208 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 22% Shared 0% None 78%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. TSHA ranks #98 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,042,829	299,975	+16.0%	Shares	Sole	2026-08-12
2026-03-31	$1,155,629	258,530	+0.4%	Shares	Sole	2026-05-12
2025-12-31	$1,415,920	257,440	-10.9%	Shares	Sole	2026-02-13
2025-09-30	$944,568	288,859	+23.8%	Shares	Sole	2025-11-06
2025-06-30	$538,821	233,256	+13.5%	Shares	Sole	2025-08-12
2025-03-31	$285,592	205,462	+7.0%	Shares	Sole	2025-05-29
2024-12-31	$332,296	192,079	+3.1%	Shares	Sole	2025-05-29
2024-09-30	$374,358	186,248	+1.1%	Shares	Sole	2024-11-12
2024-06-30	$412,796	184,284	+723.1%	Shares	Sole	2024-08-01
2022-03-31	$145,976	22,389	+13.2%	Shares	Sole	2022-05-12
2021-12-31	$230,320	19,770	-1.8%	Shares	Sole	2022-02-10
2021-09-30	$374,839	20,131	+7.8%	Shares	Sole	2021-11-12
2021-06-30	$395,825	18,671	—	Shares	Sole	2021-08-05
No filing history on record for this holder in this stock.